BREAST-Q 重建模块的临床最小重要差异值
该研究基于 3052 例乳房切除重建结局联盟(MROC)患者的前瞻性数据,采用分布法(0.2 标准差效应量和 0.2 标准化反应均值)估算 BREAST-Q 重建模块各领域的最小重要差异(MID)。结果显示各领域 MID 值为:乳房满意度 4 分、心理社会健康 4 分、身体健康 3 分、性健康 4 分,且在三个临床相关亚组中结果相似。作者建议在个体患者评估中采用 4 分(0-100 转换量表)作为临床有用的 MID 参考值。
要点
- BREAST-Q 重建模块各领域 MID:乳房满意度 4 分、心理社会健康 4 分、身体健康 3 分、性健康 4 分(0-100 量表)。
- 三个临床相关亚组间 MID 估计值相似。
- 建议在研究设计时使用相应领域的 MID 估算样本量。
核心结论
- 作者提出在 0-100 转换量表上 4 分的 MID 值在个体患者评估中具有临床实用性。
- 研究设计时应使用相应领域的 MID 估计值计算样本量。
- 分布法得出的 MID 为估计值,可能随患者人群和背景变化。
研究设计与样本
- 对 3052 例乳房切除重建结局联盟(MROC)患者前瞻性收集数据进行分布法分析。
- 采用 0.2 标准差效应量和标准化反应均值 0.2 作为分布法标准。
- 结合临床经验评估结果的适当性。
主要发现
- 3052 例患者平均年龄 49.5 岁,平均体重指数 26.8。
- 各领域 MID 估计值:乳房满意度 4 分、心理社会健康 4 分、身体健康 3 分、性健康 4 分。
- 三个临床相关亚组内各领域 MID 估计值相似。
关键数值与推荐
- BREAST-Q 重建模块 0-100 转换量表 MID:乳房满意度 4 分、心理社会健康 4 分、身体健康 3 分、性健康 4 分。
- 分布法标准:效应量 0.2 SD 和标准化反应均值 0.2。
临床怎么用
- 在个体患者随访中,BREAST-Q 重建模块评分变化达到 4 分(身体健康领域 3 分)可视为患者感知的重要变化。
- 设计研究时按目标领域的 MID 值进行样本量估算。
局限性
- 分布法得出的 MID 为估计值,可能随患者人群和背景不同而变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reconstruction module of the BREAST-Q patient-reported outcome measure is frequently used by investigators and in clinical practice. A minimal important difference establishes the smallest change in outcome measure score that patients perceive to be important. To enhance interpretability of the BREAST-Q reconstruction module, the authors determined minimal important difference estimates using distribution-based methods. METHODS: An analysis of prospectively collected data from 3052 Mastectomy Reconstruction Outcomes Consortium patients was performed. The authors used distribution-based methods to investigate the minimal important difference for the entire patient sample and three clinically relevant groups. The authors used both 0.2 SD units (effect size) and the standardized response mean value of 0.2 as distribution-based criteria. Clinical experience was used to guide and assess appropriateness of results. RESULTS: A total of 3052 patients had BREAST-Q data available for analysis. The average age and body mass index were 49.5 and 26.8, respectively. The minimal important difference estimates for each domain were 4 (Satisfaction with Breasts), 4 (Psychosocial Well-being), 3 (Physical Well-being), and 4 (Sexual Well-being). The minimal important difference estimates for each domain were similar when compared within the three clinically relevant groups. CONCLUSIONS: The authors propose that a minimal important difference score of 4 points on the transformed 0 to 100 scale is clinically useful when assessing an individual patient's outcome using the reconstruction module of the BREAST-Q. When designing research studies, investigators should use the minimal important difference estimate for their domain of interest when calculating sample size. The authors acknowledge that distribution-based minimal important differences are estimates and may vary based on patient population and context.
引用
- Voineskos SH, Klassen AF, Cano SJ, et al. Giving Meaning to Differences in BREAST-Q Scores: Minimal Important Difference for Breast Reconstruction Patients. Plast Reconstr Surg. 2020. PMID: 31577663. doi:10.1097/PRS.0000000000006317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。